UROGENITAL RADIOLOGY / ORIGINAL PAPER
Percutaneous cryoablation of renal tumours under computed tomography guidance: methodology of the procedure
More details
Hide details
1
Department of General Radiology, Interventional Radiology and Neuroradiology, Wroclaw Medical University, Wroclaw, Poland
2
Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
3
University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
Submission date: 2024-07-10
Final revision date: 2024-08-22
Acceptance date: 2024-09-11
Publication date: 2024-11-12
Corresponding author
Wojciech Tomczak
Department of General Radiology, Interventional Radiology and Neuroradiology, Wroclaw Medical University, 213 Borowska St.,
50-556 Wrocław, Poland
Pol J Radiol, 2024; 89: 526-530
KEYWORDS
TOPICS
ABSTRACT
Purpose:
The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of the percutaneous cryoablation (PCA) procedure developed based on one year of experience with 81 PCA procedures.
Material and methods:
The percutaneous cryoablation programme at Wroclaw Medical University Hospital has been successfully operating for a year. During this period, patients who were ineligible for partial nephrectomy either because of numerous comorbidities or strong preference against surgery were treated with PCA. Each procedure was conducted with the close cooperation of an interventional radiologist and a urologist.
Results:
Over the past year, 81 procedures in 74 individuals have been performed and thoroughly analysed. The mean and median effective radiation doses were 12.57 mSv and 10.76 mSv, respectively. Comprehensive details of our workflow are described within the body of the manuscript.
Conclusions:
Percutaneous cryoablation is a technically effective treatment approach for carefully selected individuals with small renal masses. However, starting a PCA programme from scratch necessitates creation of detailed protocols, as well as close interventional radiologist and urologist cooperation. This review outlines the established workflow and shares insights gained from one year of experience with percutaneous cryoablation.
REFERENCES (13)
1.
Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 2022; 82: 529-542.
2.
Uka M, Iguchi T, Okawa N, Matsui Y, Tomita K, Umakoshi N, et al. Percutaneous cryoablation for clinical T3a renal cell carcinoma (<=7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan. Jpn J Radiol 2022; 40: 1201-1209.
3.
Nouri-Neuville M, Ben Ammar M, Cornelis FH. Percutaneous image-guided renal ablations: current evidences for long-term oncologic efficacy. Presse Med 2019; 48 (7-8 Pt 2): e233-e243. DOI: 10.1016/j.lpm.2019.07.015.
4.
Vasudev NS, Wilson M, Stewart GD, Adeyoju A, Cartledge J, et al. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open 2020; 10: e035938. DOI: 10.1136/bmjopen-2019-035938.
5.
EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. Arnhem: EAU Guidelines Office; 2024. ISBN: 978-94-92671-23-3.
6.
Hasegawa T, Yamanaka T, Gobara H, Miyazaki M, Takaki H, Sato Y, et al. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol 2018; 36: 551-558.
7.
Shi H, Li J, Fan Z, Yang J, Fu S, Wang H, et al. Comparison of radiofrequency ablation versus cryoablation for T1 renal tumors: an evidence-based analysis of comparative outcomes. Front Oncol 2022; 12: 802437. DOI: 10.3389/fonc.2022.802437.
8.
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, et al. The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis. Eur Urol Focus 2019; 5: 958-969.
9.
Nowak Ł, Janczak D, Łaszkiewicz J, Guziński M, Del Giudice F, Tresh A, et al. Clinical and oncological outcomes following percutaneous cryoablation vs. partial nephrectomy for clinical T1 renal tumours: systematic review and meta-analysis. Cancers (Basel) 2024; 16: 1175. DOI:
https://doi.org/10.3390/cancer....
10.
Ge BH, Guzzo TJ, Nadolski GJ, Soulen MC, Clark TW, Malkowicz SB, et al. Percutaneous renal cryoablation: short-axis ice-ball margin as a predictor of outcome. J Vasc Interv Radiol 2016; 27: 403-409.
11.
Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37: 171-186.
12.
Rupp CC, Hoffmann NE, Schmidlin FR, Swanlund DJ, Bischof JC, Coad JE. Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation. Cryobiology 2002; 45: 167-182.
13.
Badger WJ, de Araujo HA, Kuehn DM, Angresen KJ, Winfield HN. Laparoscopic renal tumor cryoablation: appropriate application of real-time ultrasonographic monitoring. J Endourol 2009; 23: 427-430.